Evidence map›Paper›PMID 33221921›Full record

ArticleRheumatology (Oxford, England)2021

Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren's syndrome.

Pilar Jimenez-Royo, Michele Bombardieri, Coziana Ciurtin, Michalis Kostapanos, Anwar R Tappuni, Natasha Jordan, Azeem Saleem, Teresa Fuller, Kathleen Port, Elena Pontarini and 13 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Rheumatology (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02899377 (A Pilot Study to Evaluate Molecular Imaging Methods in Primary Sjögren's Syndrome), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02899377 nacompletednot on this map

A Pilot Study to Evaluate Molecular Imaging Methods in Primary Sjögren's Syndrome

TypeinterventionalSponsorGlaxoSmithKlineRan2016 to 2018Enrolled25ConditionsAutoimmune DiseasesArms18F-FDG PET/CT Imaging, 11C-MET PET/CT Imaging, MRI Imaging with intravenous contrast with gadoterate meglumine, Minor Salivary gland (labial) biopsy
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Physiological biodistribution ofFrontiers in nuclear medicine · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 3 countries.

Pilar Jimenez-RoyoResearch and Development, GlaxoSmithKline, Stevenage.
Michele BombardieriExperimental Medicine and Rheumatology, Queen Mary University of London, London.
Coziana CiurtinCentre for Adolescent Rheumatology, University College London, London.ORCID 0000-0002-8911-4113
Michalis KostapanosGlaxoSmithKline Clinical Unit Cambridge, Cambridge.
Anwar R TappuniInstitute of Dentistry, Queen Mary University of London, London.
Natasha JordanRheumatology Department, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge.
Azeem SaleemInvicro, Centre for Imaging Sciences, A Konica Minolta Company, London.
Teresa FullerResearch and Development, GlaxoSmithKline, Stevenage.
Kathleen PortResearch and Development, GlaxoSmithKline, Stevenage.
Elena PontariniExperimental Medicine and Rheumatology, Queen Mary University of London, London.
Davide LucchesiExperimental Medicine and Rheumatology, Queen Mary University of London, London.
Robert JaniczekResearch and Development, GlaxoSmithKline, Stevenage.
Paul GaletteResearch and Development, GlaxoSmithKline, Stevenage.
Graham SearleInvicro, Centre for Imaging Sciences, A Konica Minolta Company, London.
Neel PatelResearch and Development, GlaxoSmithKline, Stevenage.
Lucy KershawCentre for Inflammation Research, University of Edinburgh.
Calum GrayEdinburgh Imaging, University of Edinburgh, Edinburgh.
Nirav RatiaResearch and Development, GlaxoSmithKline, Stevenage.
André van MaurikResearch and Development, GlaxoSmithKline, Stevenage.
Marius de GrootResearch and Development, GlaxoSmithKline, Stevenage.
Nicolas WisniackiResearch and Development, GlaxoSmithKline, Stevenage.
Mats BergstromResearch and Development, GlaxoSmithKline, Stevenage.
Ruth TarziResearch and Development, GlaxoSmithKline, Stevenage.ORCID 0000-0003-3317-136X
GlaxoSmithKline (India) · INQueen Mary University of London · GBCambridge University Hospitals NHS Foundation Trust · GBCentre for Inflammation Research · GBInvicro (United Kingdom) · GBUniversity College London · GBUniversity of Edinburgh · GBUniversity of Hull · GB

Funding

Medical Research Council MR/N003063/1
6 · The paper itself

Abstract

objectivesTo assess non-invasive imaging for detection and quantification of gland structure, inflammation and function in patients with primary Sjogren's syndrome (pSS) using PET-CT with 11C-Methionine (11C-MET; radiolabelled amino acid), and 18F-fluorodeoxyglucose (18F-FDG; glucose uptake marker), to assess protein synthesis and inflammation, respectively; multiparametric MRI evaluated salivary gland structural and physiological changes.

methodsIn this imaging/clinical/histology comparative study (GSK study 203818; NCT02899377) patients with pSS and age- and sex-matched healthy volunteers underwent MRI of the salivary glands and 11C-MET PET-CT. Patients also underwent 18F-FDG PET-CT and labial salivary gland biopsies. Clinical and biomarker assessments were performed. Primary endpoints were semi-quantitative parameters of 11C-MET and 18F-FDG uptake in submandibular and parotid salivary glands and quantitative MRI measures of structure and inflammation. Clinical and minor salivary gland histological parameter correlations were explored.

resultsTwelve patients with pSS and 13 healthy volunteers were included. Lower 11C-MET uptake in parotid, submandibular and lacrimal glands, lower submandibular gland volume, higher MRI fat fraction, and lower pure diffusion in parotid and submandibular glands were observed in patients vs healthy volunteer, consistent with reduced synthetic function. Disease duration correlated positively with fat fraction and negatively with 11C-MET and 18F-FDG uptake, consistent with impaired function, inflammation and fatty replacement over time. Lacrimal gland 11C-MET uptake positively correlated with tear flow in patients, and parotid gland 18F-FDG uptake positively correlated with salivary gland CD20+ B-cell infiltration.

conclusionMolecular imaging and MRI may be useful tools to non-invasively assess loss of glandular function, increased glandular inflammation and fat accumulation in pSS.

Indexed as

AdultAgedFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPositron Emission Tomography Computed TomographySalivary GlandsSjogren's SyndromeCT scanningdiagnostic imagingMRIoutcome measures and histopathologyradionuclide imagingSS

Identifiers

PMID33221921
PMCPMC8121449
OpenAlexW3110599282

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.